Try our Advanced Search for more refined results
Life Sciences - March, 2021
358 articles
- GAO Says Feds Don't Have Patent Rights To Remdesivir
- Courtroom Shortages Mean Delay For CVS Overcharge Trial
- Oldest Opioid Suit, An MDL Bellwether, Evades Latest Assault
- Calif. Biz Group Blocks New Suits Over Prop 65 Warning
- Drug Price Checker Can Move Ahead With Antitrust Suit
- NJ Justices Lend Support To Pharma Claim Over Racial Slurs
- Mallinckrodt Seeks OK For Up To $35M In Exec Bonuses
- Distributors Can't Duck Nuisance Claim Ahead Of Opioid Trial
- Claims Court Says It Can't Hear Court Office Contract Dispute
- 5th Circ. Ruling Can't Keep Insys Exec Out Of Jail
- Groups Warn COVID IP Waiver Could Hurt Pandemic Efforts
- Illumina Antitrust Case Iced While Patents Challenged
- Union Says Del. Dispensary Refuses To Arbitrate Grievances
- 3 Cybersecurity Questions To Ask Before A Remote Mediation
- Proposed Amendments To Bayh-Dole Regulations Are Vexing
- WebMD Can't Slip Trade Secrets Suit From Argentinian Rival
- 4 Highlights As JPML Gets Earful On McKinsey Opioid Suits
- Merit Medical Can't Dodge Investor Suit Over Acquisitions
- No Jury, No Forfeiture For 'Pharma Bro' Shkreli In FTC Case
- 5-Atty Wilson Sonsini Patent Team Joins Greenberg Traurig
- FTC Challenges Illumina's $8B Deal For Cancer Detection Biz
- Biden's Pick Would Add 1st Black Judge To Fed. Circ.
- Merck Spinoff Organon To Buy Medical Device Co. For $240M
- RJ Reynolds Loses Bid To Strike San Diego Flavor Ban
- Mylan Gets PTAB To Invalidate Sanofi Injector Patent
- Coronavirus Regulations: A State-By-State Week In Review
- Expect Aggressive Health Care Scrutiny From Mass. US Atty
- Union Calls For 11th Circ. To Reinstate Zantac Claims
- Enviro Groups Settle Clean Water Suit Against PPG Inc.
- NJ Dispensary Applicant Can't Bypass Review
- Former Insys Exec Can Delay Prison To Get 2nd Vaccine Jab
- DLA Piper Snags Trial Trio In Dallas
- 1st Circ. Spikes Puerto Rico Age Bias Suit Against Drugmaker
- Generics Cos. Argue For Heritage Bellwether In Antitrust MDL
- A Uniform Mediation Act Primer As States Continue Adoption
- Health Care M&A On The Rise Despite Regulatory Uncertainty
- Judge Jackson Tapped For DC Circ. In 1st Biden Nominations
- Opioid MDL's Tribal Bellwether Dodges Early Drug Co. Attacks
- Arthrex Cleared Of Infringing TriMed Patent After Bench Trial
- McDonald's Taps Boston Scientific Atty As New GC
- Amazon Wants Ex-Worker's Privacy Claim Axed From Pot Suit
- Celebrity Trainer's Row With Greenberg Traurig Revived
- 16 Firms Could Steer IPOs Totaling $3.7B In Short Week
- Pfizer, BioNTech Call IP Suit A 'Burden' On Vaccine Effort
- Insys Brass Knew Opioid Scripts Were Bogus, 1st Circ. Told
- Digital COVID Vaccine Passports Should Be Antitrust-Exempt
- Safeguarding Privileged Communications In A Remote World
- 3rd Circ. Ruling Rejecting Ch. 11 Setoff May Provide Alternative
- Jones Day Fights Ferring's Sanctions Bid Over IP Trial
- Faruqi & Faruqi To Lead Teva Securities Suit Over Kickbacks
- Rite Aid Balks At Opioid MDL Judge's 'Tons Of Money' Remark
- Cash-Hungry Cos. Find Alternative To Volatile Markets
- Novartis Says Chair Contradicted Admissions In FCA Deal
- Mylan Settles Out Of Diabetes Drug Patent Fight At PTAB
- Insys Exec Says 5th Circ. Ruling Should Keep Her Out Of Jail
- Perkins Coie Land-Use Head Sees 4 Active Sectors Amid Virus
- Health Hires: Hooper Lundy, ClearPoint Neuro, Cue Health
- 4 Areas Of Cyberattack Vulnerability For Law Firms
- PTAB Mulls Apple's Fight Over Health Monitoring Patent
- Hologic Tells Justices Assignor Estoppel Is Settled Law
- Feds Urged To Use Moderna Vaccine Patent To Expand Access
- Cherokees Can't Widen Opioid Discovery, Companies Say
- PTAB To Review University Of Calif. Ocular Blade Patent
- Supplement Co. Hit With False Ad Case Over Weight Loss Pill
- Corteva, DuPont Aim To Dodge NJ Water Supplier's PFAS Suit
- US Ranks 2nd In Global Patent Protection For 3rd Year
- Mitsubishi Beats Bid To Invalidate Diabetes Drug Patents
- Duke Hit With Copyright, TM Suit Over Diagnostic Tool
- Bain-Backed Cleaning Products Co. Misses Bar In $692M IPO
- Real Estate Rumors: Blackstone, Chelminsky, Prologis
- Fed. Circ. Denies Another Stanford Genetics Patent Over Alice
- NYC Settles Environmental Dept. Workers' OT Suit For $332K
- How To Help Your Witnesses Overcome Hindsight Bias
- Lundbeck Loses EU Appeal Over €146M 'Pay For Delay' Fine
- Oramed Investor Suit Seeks To Claw Back Stock Awards
- Reps Urge Biden To Make COVID Vax Mandatory For Military
- 3rd Circ. Won't Touch Clinic's Win In Worker's ADA Suit
- Ex-Allied BioScience CEO Can't Nix Claim He Held IP Hostage
- Purdue, Sackler Opioid Suits Paused For Another Month
- Pharma Industry Can Expect More Scrutiny From State AGs
- HHS Nominee Clears Senate In Transgender Milestone
- Pot Trade Group Can Enter Maine Cannabis License Dispute
- 7th Circ. Should Find Patent Thickets Aren't Anti-Competitive
- GSK Says No Link Between Zofran, Defects Undermines MDL
- Vast Trove Of Big Pharma's Opioid Records Launches Online
- St. Jude Medical Beats Patent Suit Over Catheter Method
- NJ 'Reply All' Ethics Opinion Brings New Pitfalls For Attorneys
- McCarter & English Gets Mixed Ruling In Fight With Ex-Client
- Eli Lilly Loses $10M Fee Bid Over Genentech's Dropped IP Suit
- J&J Seeks High Court Holy Grail: A Cap On Punitive Damages
- Eye Diagnostic Co. Blocks Rival's Software Launch In IP Fight
- Generics MDL Special Master Says Calif. AG Merits Sanctions
- Feds Don't Want Hospital Groups In Pharma Discount Fight
- Sacklers Say No Ch. 11 Deal Without Injunction Extension
- Federal Gov't Can Learn From State Drug Pricing Efforts
- Fla. Woman Asks 11th Circ. To Revive Pelvic Mesh Claims
- Boston Scientific To Pay $188M Over Mesh False Ad Claims
- Pomerantz, Rosen Fight In Del. To Lead Walmart Investor Suit
- 3 Arthrex-Adjacent High Court Cases Could Affect PTAB's Fate
- 11th Circ. Rips FDA's 'Invisible Ink' Interpretation Of Drug Act
- Mass. Panel Partially Revives Neurologist's Retaliation Suit
- Boston Scientific Can't Duck Implant Wrongful Death Suit
- Coronavirus Regulations: A State-By-State Week In Review
- AbbVie Says Rival Used Stolen Trade Secrets To Copy Drug
- 250 Researchers, Orgs Urge WTO To Back COVID IP Waiver
- FDA Cracks Down On CBD 'Pain Relief' Products
- McKinsey To Pay Nevada $45M To End Opioid Marketing Case
- NY Hospitals Not Liable In Malpractice Suit Over Boy's Killing
- Local Gov'ts Say New $650M Bayer Deal Fixes Funds Timeline
- Mallinckrodt To Pay $267M Over Maine Mercury Contamination
- White FDA Scientist's Race-Bias Suit Comes Up Short
- States Say Time Has Come To Let Sackler Suits Proceed
- 3 Biotech Firms Join Packed Calendar Of At Least 19 IPOs
- Conn. Firefighter Axed Over Pot Use Has ADA Suit Tossed
- Judging A Book: Bibas Reviews Rakoff's 'Why The Innocent Plead Guilty'
- High Court Won't Hear Generic MS Drug Patent Challenge
- Couples Aim To Revive $83M J&J, Bard Mesh Verdicts
- 3 Firms Seek $4M For CytoDyn Stock Award Suit Settlement
- Axogen Stock Offering Suit Axed Again, But Appeal Looms
- Greenberg Traurig Adds Jones Day IP Atty In Los Angeles
- Novartis Names Longtime AbbVie Atty As CLO
- AstraZeneca Calls Virus Vaccine 'Highly Effective'
- As AG Takes Wheel At HHS, Biden Faces Rocky Legal Road
- Omnicare, CVS Can't Toss FCA Suit Over Prescription Scheme
- Allergan Must Face Breast Implant, Class Claims In MDL
- Biotech CEO Lied About Home COVID-19 Test, Investors Say
- Sanofi Says Insulin Pen Buyers Can't Expand Antitrust Case
- Bayer Skips High Court Review Of $21M Roundup Verdict
- 3rd Circ. Won't Cut McKesson's Debt To Obesity Drug Co.
- HHS Halts 'Ticking Timebomb' Sunset Rule After Being Sued
- Immunomedics Broke Exit Deal With Founder, Chancery Told
- Sackler Act Would Ban Release Of Nondebtor Gov't Claims
- Breaking IP Barriers: Q&A With White & Case's Anita Varma
- Mallinckrodt Investor Can't Call Meeting To Replace Board
- DOJ Says Atty Wall Can't Fix Morgan Lewis, Glenmark Conflict
- Justices Told Arthrex Win Means USPTO Can't Cancel Patents
- 3 Biotech Firms, Cannabis REIT Price IPOs Totaling $758M
- Health Hires: Orrick, K&L Gates
- For Law Firm Digital Marketing, Less Is Sometimes More
- Must Pharmacists Investigate All Prescriptions For Fraud?
- Indian Biopharma Valued At $350M In Funding Rounds
- Investors Launch Suit Over Reckitt's $1.4B Suboxone Deal
- Pillsbury, Ropes & Gray Steer Health Tech Co. $1.2B Go-Public
- Opioid Distributors Argue 'Nuisance' Trial Theory Is Nonstarter
- AbbVie Asks High Court To Review Sham Litigation Exception
- AbbVie Loses Judge-Switch Bid In Humira Kickback Battles
- Walgreens Inks $3.3M Deal Over Pharmacy Tech Wage Claims
- Justices Asked To Undo 'Dangerous' Patent Case Ruling
- Feds Charge Fecal Testing Startup Founders With Fraud
- Deals Rumor Mill: Chubb, AbbVie, NMC Health
- GW Pharmaceuticals Investors Sue To Stop $7.2B Acquisition
- Drug Co. Owed Defense In Opioid Suits, Ohio Justices Told
- Chinese IoT Platform Developer Leads 4 IPOs Topping $1.5B
- Paul Weiss, Davis Polk Rep Insurtech's Planned $490M IPO
- Mintz Adds Haug Litigation Partner With Life Sciences Chops
- Inventors, Tech Are Taking The Brunt Of Alice Axes
- Unvaccinated Insys Exec Asks For Another Prison Delay
- Climate Change Plaintiffs Are Getting Creative
- Health Tech Co. Can't Boot Klamann From ERISA Arbitrations
- Coppertone Buyers, Bayer Ink $2.25M Deal In False Ad Suit
- Levi & Korsinsky Earns $2.1M For Illumina Shareholder Suit
- Okla. Dodges Suit Over Pot License Residency Rules
- PTAB Reveals Route To IPR Institution Denial In Parallel Cases
- Calif. AG Wins Senate Confirmation To Lead HHS
- 2nd Circ. Says Chinese Regs Key To Vitamin Price-Fixing Case
- Pharmacies Rip FDA Bid To End Compound Drugs Reg Case
- Immunocompromised Atty Gets IP Trial Moved To Sept.
- UK Looks Determined To Grab A Larger Share Of SPACs
- Calif. Must Share Rx Data With Walgreens In Opioid Row
- Hand Sanitizer Buyers Want Cert. In CVS False Ad Suit
- States Push New Bellwether Generic Drug Price-Fixing Case
- Aceto Investors Can't Resurrect Securities Suit
- Teva Sues BioMarin In UK Over Genetic Disorder Drug Patent
- Ex-Theranos CEO Holmes' Trial Delayed Due To Pregnancy
- AbbVie Denies Judge-Shopping In Humira Kickback Cases
- Eli Lilly Wins Bid To Block HHS Drug Discount Rule
- Crest Buyers Say They Were Duped By Charcoal Toothpastes
- McKinsey Opioid Deal With NY AG Approved Amid Objections
- PhRMA Can't Get Minn. Insulin Pricing Law Overturned
- Drug Return Co., Execs Want 3rd Circ. To Undo $94M Verdict
- Purdue's Ch. 11 Plan Hangs On Sackler Liability Question
- FTC Leads International 'Rethink' Of Pharma Merger Reviews
- Fox Rothschild Gets Copyright Pro From Taft Stettinius
- AstraZeneca Resets FTC Review Clock For $39B Alexion Deal
- Coronavirus Regulations: A State-By-State Week In Review
- Express Scripts Fights Workers' Cert. Bid In 'Manager' OT Suit
- Protecting Trade Secrets In The Remote Workplace
- Strategies For Fighting Back Against A Rambo Litigator
- Generics Call Alcon Glaucoma Drug Obvious As Trial Begins
- Teva Sues BMS, Pfizer Over UK Blood Thinner Patents
- Purdue Files Ch. 11 Plan That Draws Criticism From State AGs
- Astellas Aims To Block Generic In Incontinence Drug IP Fight
- US Cos.' Patent Filings In Europe Dropped 4% Amid Pandemic
- As Justices Mull Abortion Showdown, Circuit Split Deepens
- Biotech Co. Says It Never Lied About Its COVID Vaccine Work
- J&J Unit Wins Another Shot At Medical Stapler IP Amendment
- Glenmark Rips DOJ's 'Misplaced' Morgan Lewis Conflict Claim
- Spinal Device Co. Wins Ban Against Rival, But Must Pay Bond
- Becton Beats Antitrust Suit After 7th Circ. Revival
- Hearing Aid Co. Settles Workers' Stock Plunge Suit
- 8th Circ. Told $75M Dicamba Ruling Riddled With Errors
- Vitamin C Price-Fixing Case: Round 2 At The 2nd Circ.
- Cooley-Led DigitalOcean Leads 5 Planned IPOs Totaling $2B
- GameStop Frenzy No Reason To Jettison Securities Theory
- Court Erred In Barring Late DOJ Intervention In FCA Case
- Ill. City Wants Acthar Cases In MDL, Out Of Bankruptcy
- DLA Piper, Sidley Guide $1.8B Deal For Disease Testing Biz
- Acer Therapeutics Derivative Settlement Gets Initial Nod
- Law Firm Admonished For 'False' Ads In Gilead HIV Drug Suit
- Fed. Circ. Affirms Letting J&J Reveal Manufacturer In IP Row
- Health Hires: Holland & Knight, AavantiBio
- Fed. Circ. Calls Route To PTAB Denial Appeals 'Very Narrow'
- Minn. AG's Insulin Suit Against Sanofi, Eli Lilly Gutted
- Convertible Bond Offerings Ride To New Heights
- Charting A Year Of The Biggest COVID Scams Cited By FDA
- Pool Equipment Biz Raises $685M To Lead IPO Pack
- NJ Court Skeptical Of FCA Claims Against Gilead, Shire
- Justices Told Fed. Circ. Muddied Inventorship Law In IP Row
- Pharma Co. Seeks J&J Virus Vaccine License — Or Else
- Ex-Theranos CEO Holmes Pregnant, Wants July Trial Delayed
- Nev. Justices Say Insurer Can Recoup Costs From Implant Co.
- ITC Keeps Probe Of Russian, Indian Polymer On Track
- Real Estate Rumors: Hersha, Wayne Rosen, Oaktree
- Skadden, Kirkland Guide Co.'s $1B Sale Of Medical Device Biz
- 1 Year Into Pandemic, It's Time To Rethink Law Firm Billing
- LG Chem Beats Suit Over Genetic Database License, For Now
- The Defining Pandemic Moments For Health And Life Sci Attys
- Arnold & Porter Accused Of Conflicts In Mallinckrodt Ch. 11
- Smoker's Wife Can't Collect $1.3M More From Philip Morris
- WTO Fails To Reach Deal On COVID IP Waiver Proposal, Again
- Ohio Ordered To Respond To Pot Grower's Expansion Request
- Senate OKs Drug Exclusivity Change To Boost Generics
- Why A Surge Of COVID Securities Suits Hasn't Happened
- What One Firm's Filings Reveal About Labeling Class Actions
- What Companies Should Know About SIGPR Oversight
- Hashing Out IP And Legality Questions On Delta-8 THC
- Supplement Maker Must Face Trimmed Claims Of Harm
- How Biden's Leadership Picks Will Shape Health Priorities
- Fed. Circ. Axes Stanford's Genetic Analysis Patent As Abstract
- Rogue High Court Citation May Spark Legal Writing Changes
- Dermatology Biz Says UK Lab Breached $1M Licensing Deal
- Deals Rumor Mill: Shutterfly, Cooper, Apax Partners
- Trading Firm Says 3rd Time's The Charm For $3.6M Award
- Verano, Harvest Hit With RICO Suit By Ex-Worker After Arrest
- Ariz. Pot Co. Ends Extortion Suit Against Exec Over License
- Mass. Federal Judge Is Latest To Take Senior Status
- Vanda Pharma Can't Nix Investors' Off-Label Fraud Suit
- Scotts, Acreage Were Top Spenders In NJ Legal Pot Effort
- Mallinckrodt Adds Senior Lenders To Ch. 11 Plan Supporters
- FDA Scolds Drug Co. Over Kardashian Promo On 'The View'
- House Sends $1.9T Virus Relief Package To Biden
- Pleading Tortious Interference Claims In Calif. After Ixchel
- The Case For Diversity In Internal Investigation Teams
- Providence Health & Services CLO Dies At 53
- Trump's HHS Left 'Ticking Timebomb' For Old Rules, Suit Says
- Westco Workers Win Class Cert. In 'Secret' Pension Suit
- J&J Aims To Sink $117M Talc Verdicts With 'Seismic' Impact
- CBD Co. Zynerba, Investors Aim To Settle Drug Trial Claims
- Pot Co. Wins $15M In Brawl Over Columbia Care Fla. License
- Freezer Co. Denied Early Win In Suit Over Destroyed Embryos
- Teva Investors Win Class Cert. In Securities Suit
- Coronavirus Regulations: A State-By-State Week In Review
- Calif. Enviro Group Wins Water Well Fight On Appeal
- Fed. Circ. Backs Becton PTAB Wins On 2 Drug Dosing Patents
- WTO Chief Calls Unequal Vaccine Delivery 'Unconscionable'
- Opioid Distributor, Execs Can't Escape DOJ Indictments
- Key Insights From DOJ's 2020 Fraud Enforcement
- 'No Room For Error': Novavax Deal Hits Home For Ropes Atty
- COVID-19 Drugmaker Eli Lilly Appoints New Compliance Chief
- Ferring Urges Sanctions For Jones Day Over 'Forced' IP Trial
- McKinsey Seeks New MDL As Opioid Headaches Worsen
- Justices Told Thyroid Drug Patent Ax Flouts Global Pact
- NY AG Opioid Trial Now Set For June Amid Virus Concerns
- Fed. Circ. Won't Undo Amgen's Cancer Drug IP Win
- Ex-Med Tech Exec Cops To Obstructing Feds' Purdue Probe
- Sandoz Fights FDA Exclusivity For Sanofi Blockbuster
- Ariz. High Court Allows Costco Privacy Suit To Proceed
- Cal State Univ. Gets $2.9M PAGA Safety Fine Axed On Appeal
- Food-Ordering Co. Olo Tops 4 IPO Launches Totaling $706M
- Sens. Tell USPTO That Patent Eligibility Rules Hurt Innovation
- Merck Can't Escape Union OT Back Pay Bid In Arbitration Row
- DOJ Worried Over Morgan Lewis Generic Price-Fixing Conflict
- Health Info Blocking Rule Creates Opportunities For Research
- 5 Ways Outside Counsel Can Impress Their Clients
- Moderna Taps Ex-Novartis CLO As Top Lawyer
- Overlooked PTAB Cases: Raising Nonobviousness Evidence
- Attys Seek To Delay $2B Roundup Deal Hearing
- GW Pharma Wants Out Of Canopy's CBD Patent Dispute
- AdventHealth Reaches Deal On COVID-19 PPE Fraud Claims
- Senate Approves $1.9T Virus Relief Plan With Changes
- Another CBD Co. Gets Consumer Suit Halted Over FDA Delay
- Roundup Claimants Slam 'Frankenstein-ian' $2B Bayer Deal
- Walgreens Settles PAGA Off-Duty Break Suit For $6.8M
- Opioid Litigation Is Prying Open Vaults Of Big Pharma Secrets
- US Extends China Tariff Cuts On Virus Response Gear
- Billionaire Frost, OPKO Execs Sued Over Leadership Diversity
- How Drug Cos. Can Adapt To New Reference Pricing Rules
- Health Hires: Mintz, Apria, DBV Technologies
- Declaratory Judgments Unavoidable For Biosimilar Applicants
- Landmark NY Opioid Trial Delayed Amid Virus Concerns
- DOJ's 'Troubling' Theory Gains Walmart Allies In Opioid Case
- FDA Tells Osteopath To Stop Marketing Fake COVID-19 Cures
- Pot Co. Says Trade Group Has No Stake In Maine License Row
- FDA Seeks Win In Suit Over Compounded Drug Agreements
- Dust Spray Maker Can't Dodge Suit Over DUI Death
- 'Pharma Bro' Shkreli Hit With 1st Private Antitrust Suit
- NH High Court Says Insurers Must Cover Workers' Medical Pot
- Teva Faces EU Antitrust Probe Over MS Drug Patent Strategy
- Germ-X Maker Beats Hand Sanitizer False Ad Suit, For Now
- Deals Rumor Mill: Robinhood, Flipkart, Permira
- 2 Firms Guide Amgen's $1.9B Deal For Cancer Drug Biz
- Ethics Tips For Attorneys Telecommuting Across State Lines
- Emory Says Ex-Worker's 2 Discrimination Suits Split Claims
- 1st Circ. Says Abbott Doesn't Owe $1M Age Bias Verdict
- CEO In $150M Opioid Scheme Hit With 15-Year Sentence
- Pharma Cos. Held In Contempt In Trade Secrets Case
- Del. Justices Reverse GSK's $57M Lupus Drug Patent Loss
- Latham, Ropes Guide $1.07B Boston Scientific-Lumenis Deal
- NY Opioid Trial Defendants Want New COVID-19 Delay
- Reckitt Benckiser Coughs Up $53M To End False Ad Suit
- Okla. Seeks 19-Year Extension To J&J $465M Opioid Judgment
- Senate Caucus Presses For New Pot Research Regulations
- J&J Blasts 'Tainted Process' In Imerys Ch. 11 Case
- AstraZeneca Beats Mylan Challenge To Inhaler IP's Validity
- Abbott Labs Sales Director's Age Bias Case Teed Up For Trial
- 6 Ways Legal Employers Can Help Pandemic-Weary Parents
- Health Cos. Can Reduce FCA Risk By Leveraging Data
- Charlotte's Web Signs Deal To Enter Pot Biz Upon Legalization
- Questions Loom About DOJ Dismissal Power In FCA Suits
- 10th Circ. Says Nurse Must Face Wrongful Death Suit
- Big Tobacco Wins 3rd Delay Of Graphic New Warning Labels
- After J&J-Merck Deal, Biden Vows Vaccines For All By May 31
- Supreme Court Urged To Rein In Use Of Assignor Estoppel
- Hospital Groups Want To Join Fight Over Drug Discount Rule
- Chamber Urges WTO Not To Entertain Vaccine IP Waivers
- Fla. Sens. Introduce Cannabis Legalization, Taxing Proposals
- Insys Founder Says 'Spillover Prejudice' Warrants New Trial
- Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
- J&J Urges High Court To Nix $2.1B Talc Verdict
- AdventHealth, Atty Settle In Fraud Suit Over $57M PPE Deal
- 3 Degrees Of Legalization Show True Prevalence Of Cannabis
- Va. Legislature Approves Recreational Cannabis, Tax On Sales
- Alsup Won't Budge On Sanction For Ex-MLB Player's Atty
- J&J, Bard $83M Pelvic Mesh Verdicts Overturned
- Biotech Exec Admits Insider Trading On Dimension Deal Talks
- Coronavirus Regulations: A State-By-State Week In Review
- Remote Working Tips For Lawyer Trainees And Their Firms
- PQ Group Offloads Performance Chemicals For $1.1B
- Ex-Amazon Worker Says Medical Marijuana Use Got Him Fired
- SPACs Power Another Record-Breaking Month For IPOs
- Justices Suggest PTAB Will Survive, But With More Oversight
- FTC Alums Join Gibson Dunn's Antitrust Group As Partners
- Otterbourg Adds New York Deals Pro From Akerman
- EpiPen Ruling Could Embolden Private Anti-Kickback Claims
- Fed. Circ. Backs $173M Bayer Patent Win On Hemophilia Drug
- J&J Brushes Off ERISA Suit Over Asbestos In Baby Powder
- 3 Firms Direct $1.55B Sale Of Perrigo Unit To PE Firm
- Purdue Promises Ch. 11 Plan In 2 Weeks